04-27-1987 Council Packet - Laserfiche WebLink

Home Browse Search

152.02 PROHIBITED DRUGS 3598 (g) Not more than 500`1 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non -narcotic ingredients in recognized therapeutic amounts. (h) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non -narcotic ingredients in recognized therapeutic amounts. Subd. 5. The following items are listed in Schedule IV: Barbital; Chloral betaine; Chloral hydrate; Chlordiazepoxide; Clonazepam; Clorazepate; Diazepam; Diethylpropion; Ethchlorvyno�l; Ethinamate; Fenfluramine; Flurazepam; Mebuta- mate; Methohexital; Meprobamate except when in combination with the following drugs in the following or lower concentrations: conjugated estrogens, 0.4 mg; tridihexethyl chloride, 25mg; pentaerythritol tetranitrate, 20 mg; Methylphenobar- bital; Oxazepam; Paraldehyde; Pemoline: Petrichloral; Phenobarbital; and Phen- termine. Subd. b. The following items are listed in Schedule V: Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs, which shall include one or more non -narcotic active medicinal ingredients in sufficient proportion to confer .ip on the compound, mixture or preparation saluable medicinal qualities other than these possessed by the narcotic drug alone; (1) Not niore than 100 milligrams of dihydrocodeine per 100 millilitcrs or per 100 grams. (2) Not more than 100 milligrams of ethclmorphine per 100 milliliters or per 100 grams. (3) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit. (4) Not more than 15 milligrams of anh,,dmus morphine per 100 milliliter,% or per 100 grams. Suhd. 7. The hoard of pharmacy is authorized to regulate and define addition- al substances which contain quantities of a substance possessing abuse potential in accordance with the following criteria: (1) The board of p! —i macy shall ;dace a substance in Schedule I if it finds that the substance has: A hign potential for abuse, no currently accepted medical use in the United States, and a lack of ac,-!pted safety for use under medical superOsion. (2) The board of pha-tnacy shall place a substance in Schedule 11 if it finds that the substance has A high potential for abuse, currently accepted medical use in the United States, or currently accepted medical use with seiere restrictions, and that abuse may lead to se% ere psychological or physical dependence. (3) The board of pharmacy shall place a substance in Schedule III if it finJ% that the substance has: A potential for abuse less than the substances listed in Schedules I and 11, currently accepted medical use in treatment in the United Statm and that abuse may lead to moderate or low physical dependence or high psycholog+ cal dependence. (4) The beard of pharmacy shall place a substance in Schedule IV if it rinds that the substance has: A low potential for abuse relatv.e to the substances in Schedule 111. currently accepted medical use in treatment in the United States, and that -A"W" may lead to limited physical dependence or psychological dependence rela+i,.t to the substances in Schedule III 0) The board of pharmacy shall place a wh%tancc in Schedule V if it fend+ that the substance has A low potential for abuse relative to the substances ' steel i^ Schedule 1V. currently accepted medical use in treatment in the United State•, and IimiteJ physical dependence and 'or ps,.chologieal dependence lability rel.3ti`ie to tlW substances listed in Schedule IV.